MAYNF Stock News Mayne Pharma (MAYNF) 0.8200 07/25/2014 06:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mayne Pharma (MAYNF) 0.8200 $MAYNF

HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials and Finalizes Key Agreement with Mayne Pharma
PR Newswire - Wed Jun 25, 8:15AM CDT
HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has closed a $1.5 million interim private common stock financing. The funds were secured from Hedgepath, LLC, HPPI's current majority stockholder. Under the terms of the financing, Hedgepath, LLC will purchase 20 million shares of HPPI common stock for gross proceeds of $1.5 million, which proceeds will be funded in pre-agreed to monthly tranches during the remainder of 2014.

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2014
M2 - Thu Jun 12, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zp6w5m/onychomycosis) has announced the addition of the "Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Onychomycosis (Tinea Unguium) and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Onychomycosis (Tinea Unguium) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Onychomycosis (Tinea Unguium) and enlists all their major and minor projects Companies Mentioned: - Actavis plc - Eisai Co., Ltd. - Nihon Nohyaku Co., Ltd. - Helix BioMedix, Inc. - Kaken Pharmaceutical Co., Ltd. - Apricus Biosciences, Inc. - NovaBay Pharmaceuticals, Inc. - Nuvo Research Inc. - Mayne Pharma Group Limited - Evolva SA - Novabiotics Ltd - Anacor Pharmaceuticals, Inc. - NB Therapeutics, Inc. - NanoBio Corporation - Moberg Pharma AB - Viamet Pharmaceuticals, Inc. - Celtic Pharmaceutical Holdings L.P. - Meiji Seika Pharma Co., Ltd. For more information visit http://www.researchandmarkets.com/research/zp...chomycosis

HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma
PR Newswire - Tue Sep 10, 3:01PM CDT
HedgePath Pharmaceuticals, Inc. (OTCPink: HPPI) (HPPI) announced today that it has signed an exclusive Supply and License Agreement with Mayne Pharma International Pty Ltd (Mayne Pharma), a wholly owned subsidiary of Mayne Pharma Group Limited, an Australian ASX listed company, whereby HPPI will pursue clinical development of Mayne Pharma's patented formulation of the drug itraconazole, known as SUBA-Itraconazole, for treatment of a variety of cancers with a focus on seeking regulatory approvals and marketing in the United States.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 51

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
RBI Prices $1 Billion of Secured Notes Due 2031, 2036

Updated Category News Views 222

A billion dollars of fresh paper just landed on Restaurant Brands International’s balance-sheet doorstep, and this one deserves more than the usual sleepy glance at a financing release. RBI has priced $500 million of 6.00% senior secured notes due 2031 and another $500 million of 6.40% senior secured notes due 2036. The expected closing date is November 24, 2026,...

Continue Reading
BioArctic's Q3 Call Puts Leqembi Economics Under Watch

Updated Category News Views 32

One Date, Several Unanswered Questions November 25 lands with an unusually clean checklist for BioArctic watchers: results arrive at 8:00 a.m. CET, then management takes the floor at 9:30 a.m. CET. That is the whole immediate event, and it matters because this is not a company investors can sensibly judge by a single headline or a vague promise about neuroscience....

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 0

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 69

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 189

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 135

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 197

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into 1st Colonial Bancorp's Sale

Updated Category News Views 256

Exploring the Sale of 1st Colonial Bancorp, Inc. In a significant development for shareholders, the M&A Class Action Firm has initiated an investigation into 1st Colonial Bancorp, Inc. (OTCMKTS: FCOB) regarding its proposed acquisition by Mid Penn Bancorp, Inc. This merger, which has garnered attention in the financial community, raises important questions about the...

Continue Reading
American Tungsten Pursues $10 Million Investment Opportunity

Updated Category News Views 181

American Tungsten Seeks $10 Million Through Private Placement American Tungsten Corp. (CSE:TUNG) (OTCQB:TUNGF) has announced an exciting initiative to raise up to $10 million through a non-brokered private placement, aiming to issue over 2.8 million common shares priced at $3.50 each. This move reflects the heightened demand for critical metals and underscores the...

Continue Reading
Arcadia Biosciences Surpasses Revenue Goals in Q3 2025

Updated Category News Views 188

Arcadia Biosciences Reports Strong Financial Results Arcadia Biosciences, Inc. (NASDAQ: RKDA), a leader in the wellness products sector, recently revealed its financial and operational highlights for the third quarter of 2025. This report showcases the continued growth and resilience of the company amid various market challenges. Year-to-Date Performance As of the third...

Continue Reading
Artificial Superintelligence Alliance Sees Strong Price Gains

Updated Category News Views 71

Overview of Recent Price Movements In the past 24 hours, the price of Artificial Superintelligence Alliance has seen an impressive increase of 5.78%, reaching $1.35. This surge is part of a broader upward trend throughout the week, where it has lifted by 3.0% from $1.33. It's worth noting that the coin's all-time high is recorded at $3.45. Analyzing Volatility and Trends...

Continue Reading
How Bitcoin Boosted Robert Kiyosaki's Wealth Journey

Updated Category News Views 311

Robert Kiyosaki's Insights on Bitcoin Robert Kiyosaki, known for his influential book "Rich Dad Poor Dad," recently shared his experiences and beliefs about Bitcoin, a digital asset he credits for significantly enhancing his wealth. He has gained notoriety as a financial guru, and his comments on Bitcoin have sparked considerable interest in the cryptocurrency market....

Continue Reading